The company plans to use Thermo Fisher Scientific's newly launched PharmacoScan array-based platform for its testing.
BIG offers free use of the warehouse to internal researchers and is reaching out to local companies in the Buffalo area working in genomics and other areas.
DNAstack offers cloud-based access to bioinformatics solutions and mechanisms for sharing genomic data that leverage open APIs and resources.
The company has been working with NGS-based ctDNA testing for some time in research, but has now made its first move into the clinical sphere.
The app lets physicians use their mobile phones to access clinical trial matching capabilities from the broader GenoSpace portfolio.
Frameshift plans to commercialize two applications: one for data quality control and a second for identifying mutations in rare and Mendelian disorders.
Living DNA can break down the origins of a customer’s ancestry into 21 distinct regions within Britain alone, as well as across 80 different worldwide populations.
The platform features a more comprehensive list of pipelines, simplifies data movement and flow, and reduces analysis times.
The launch follows a beta that kicked off earlier this year to put the software through its paces with data curators and other scientists.
Early backers can get their genome or exome sequenced at discounted rates of $999 and $399, respectively, limited to the first 10 and 50 users in each case.
The Wall Street Journal speaks with patients affected by questionable test results from Theranos.
Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.
Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.
In Science this week: convergent evolution in bird hemoglobin, and more.